Roger was Director at Chelsea Therapeutics International, and Chief Executive Officer at Cortex Pharmaceuticals. Roger Stoll joined Delcath Systems in 2008. Roger served as Director at Delcath Systems.
Roger Stoll is currently Director at Delcath Systems - View - Delcath Systems org chart
Create your alert
to follow the career of Roger Stoll.
Roger Stoll has a Ph.D., Biopharmaceutics and Pharmacokinetics from University of Connecticut in 1970 and a Post-Doctoral Studies, Pharmacokinetics from University of Michigan in 1972.
They have also studied at University of Connecticut :
Find more alumni from University of Connecticut
They have also studied at University of Michigan :
Find more alumni from University of Michigan
Do you need to know more about Roger Stoll? More results.
Report an error
Update the org chart details of Roger Stoll.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.